Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics (clinical),Oncology,Genetics
Link
http://link.springer.com/content/pdf/10.1007/s10689-007-9147-7.pdf
Reference45 articles.
1. Foulkes WD (2006) BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis. Fam Cancer 5(2):135–142
2. Anonymous, Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 1997;349(9064):1505–1510
3. Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90(15):1138–1145
4. Lakhani SR, Van de Vijver MJ, V, Jacquemier J et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318
5. Chappuis PO, Kapusta L, Begin LR et al (2000) Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. J Clin Oncol 18(24):4045–4052
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PARPi: Efficacy in Hereditary Breast Cancer;Hereditary Breast and Ovarian Cancer;2021
2. Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration;Journal of Human Genetics;2020-10-09
3. BRCA mutations and reproduction;Fertility and Sterility;2018-01
4. Genetic Testing for Hereditary Breast Cancer: The Decision to Decline;The American Surgeon;2018-01
5. Approaches for Identifying Novel Targets in Precision Medicine: Lessons from DNA Repair;Advances in Experimental Medicine and Biology;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3